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THE HARVEY LECTURES, SERIES 75 
CELLULAR ORIGIN OF TRANSFORMING GENES OF 
RNA TUMOR VIRUSES* 
HIDESABURO HANAFUSA 
The Rockefeller University, New York, New York 
IN the past decade, RNA tumor virus research has attracted agreat deal of attention, as a model system of viral carcino­
genesis and perhaps in part because of the discovery of reverse 
transcriptase in virions which catalyzes the synthesis of DNA 
using RNA as a template (Temin and Mizutani, 1970; Baltimore, 
1970). Recently there seems to be another surge of interest in 
the RNA tumor viruses. One reason for the renewed interest is 
the long awaited identification of the viral gene product which 
is directly responsible for cell transformation (Brugge and 
Erikson, 1977; Purchio et al., 1977). Another factor is the dis­
closure of the unique mechanism with which virus is able to 
integrate into host cell DNA and regulate the expression of the 
integrated provirus. These two aspects will be parts of the dis­
cussion presented, which will focus on the possible general pro­
cess in the evolution of the oncogenic viruses and its implication 
to the understanding of the process of cell transformation. 
I. RNA TUMOR VIRUS AS A TRANSFORMING AGENT
The RNA tumor virus systems have developed into a large 
family of viruses since isolation of viruses early this century by 
Ellermann and Bang (1909), Rous (1911), and Fujinami and In­
amoto (1914). The viruses are classified into three major groups: 
sarcoma, acute leukemia, and lymphoid leukosis viruses, on the 
basis of their pathogenicity in infected animals (Hanafusa, 1977). 
Typical RNA tumor viruses of avian species are listed in Table 
I. In addition to Rous sarcoma virus (RSV), two independent
*Lecture delivered March 20, 1980.
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TABLE I 
AVIAN RNA TUMOR VIRUSES 
Acute leukemia Lymphoid 
Sarcoma virus virus leukosis virus 
Virus strains Rous sarcoma virus Avian Avian 
(RSV) myeloblastosis lymphomatosis 
Bryan strain virus (AMY) virus RPLl2 
(BH-RSV) Avian Rous associated 
Schmidt-Ruppin erythroblastosis viruses (RAV s) 
strain (SR- virus (AEV) Resistance 
RSV) Avian inducing factor 
Prague strain myelocytomato- (RIF) 
(PR-RSV)· sis virus 
Bratislava strain 77 (MCV) 
(B77) 
Fujinami sarcoma 
virus (FSV) 
Target cells Fibroblasts Bone marrow Bursa of 
cells Fabricius 
(fibroblasts) 
(epithelial cells) 
Latent 5-10 days 1-3 weeks 4-6 months 
period (in 
vivo) 
Virus + or - + 
replication 
isolates, Fujinami sarcoma virus (FSV) and Bratislava 77 (Thurzo 
et al., 1963), are known as sarcoma viruses, and recently more 
additions have been reported (Carr and Campbell, 1958; Itohara 
et al.,· 1978). There are a number of "strains" of RSV which 
are called by the name of researchers or by the name of the 
place where the original Rous virus was passaged and acquired 
some altered properties (Hanafusa, 1977). Acute leukemia vi­
ruses and lymphoid leukosis viruses, the second and third groups 
(Table I), are distinguishable on a number of accounts. First, 
acute leukemia viruses, as indicated by the name, cause an acute 
type of leukemia in animals compared to lymphoid leukosis_ vi­
ruses, which need a long latent period of several months. The 
primary target tissues are different: the bone marrow for acute 
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leukemia virus and the bursa of Fabricius for leukosis viruses. 
Perhaps more importantly, all of the acute leukemia viruses are 
defective in virus replication because of the substitution of their 
genomes by inserts of unique sequences, presumably derived 
from host cells. Therefore, as will be further discussed later, our 
current understanding is that acute leukemia viruses, and also 
sarcoma viruses, are able to transform host cells because they 
incorporate their unique transforming sequences into the cells. 
On the other hand, lymphoid leukosis viruses do not appear 
to have such specific cellular sequences within their genome. It 
is considered, therefore, that leukosis viruses cause tumors in 
lymphoid cells because of replication of the virus for a long 
period of time, thereby altering the expression of some host cell 
genes. The mechanism of tumor formation by leukosis viruses 
is one of the issues actively being pursued by many groups and 
will not be discussed here. It should be stressed, however, that 
leukosis viruses are not defective in replication and serve as 
helper viruses for both defective sarcoma virus and defective 
acute leukemia viruses. 
Cell transformation by avian sarcoma virus is a rapid and 
quantitative process (Hanafusa, 1969). Upon infection with one 
or more infectious virus, cells change dramatically in their ap­
pearance: cells which we call morphologically transformed be­
come more refractile and assume either a round or spindle shape 
due to the changes in cell surface. These morphological changes 
are generally associated with changes in a number of other cel­
lular phenotypes, including the capacity of continuous growth 
under conditions where normal cells cannot grow (Hanafusa, 
1977). 
These changes can take place within 24-30 hours following 
introduction of a single virus into the cell. After infection, viral 
genome RNA is copied into DNA by reverse transcriptase which 
is associated with viral RNA within the viral particles. Double­
stranded viral DNA thus formed will be integrated into cellular. 
DNA, and thereafter transmitted to daughter cells by cell division 
(Varmus et al., 1975; Gaianni et al., 1975; Weinberg, 1977). Re­
cently it was discovered that in the process of the synthesis of 
viral DNA using viqll RNA templates, the nucleotide sequences 
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present at the termini of viral RNA are duplicated and added to 
both ends of linear DNA in a form of direct repeats (Shank et 
al., 1978; Hsu et al., 1978). Furthermore, these long terminal 
repeats (LTR) are preserved in the integrated proviral DNA, and 
they are flanked by cellular sequences, suggesting that the LTR 
is directly involved in the process of integration of viral DNA 
(Hughes et al., 1978; Sabran et al., 1979; Hager et al., 1979; 
Vande Woude et al., 1979). As the nucleotide sequences of the 
LTR of various retrovirus have been analyzed, it has become 
apparent that these terminal sequences contain a set of sequences 
similar to those found in other eukaryotic DNAs which may 
serve as a promoter of RNA transcription (Yamamoto et al., 
1980; Sutcliffe et al., 1980; Blair ei al., 1980). This means that 
the proviral DNA transcription is not controlled by a cellular 
promoter but. rather by its own promoter signal introduced into 
the cell chromosome together with the coding sequences of the 
viral genome. 
The primary transcript of RSV provirus appears to be the 39 
S RNA which is the same size as the genomic RNA found in 
virions. This RNA contains four defined genes: gag for viral 
structural proteins, pol for the reverse transcriptase and env for 
envelope glycoproteins, and src for the transforming protein. 
The first three genes are essential for making complete virus and 
are shared by both lymphoid leukosis virus and nondefective 
strains of RSV. The src gene codes for a 60,000-dalton protein 
which is considered to be responsible for cell transformation and 
sarcoma formation (Brugge and Erikson, 1977; Purchio et al., 
1977). The four genes described above are mapped on the non­
defective RSV genome in the order 5'-gag-pol-env-src-c-poly(A)-
3' (Wang, 1978). The sequences known as "c" are commonly 
present in most avian retroviruses, and a portion of it forms a 
part of the LTR which includes the promoter sequences. The 
corresponding genetic structure of lymphoid leukosis virus ge­
nome is shown by 5 '-gag-pol-env-c-poly(A)-3'. 
II. GENERATION OF NEW SARCOMA VIRUSES 
Historically, the comparison of RN As of these two types of 
viruses led to the recognition of the presence of the src gene. 
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When nondefective RSV is passaged in tissue cultures, usually 
a mutant is segregated, which retains replicating capacity but 
not transforming capacity (Vogt, 1971; Kawai and Hanafusa, 
1972; Martin and Duesberg, 1972). The mutants are called trans-
. formation defective or td mutants. The RNA of td mutants is 
smaller than that of RSV and characteristically lacks a specific 
portion of the RN A sequences near the 3' end (Dues berg and 
Vogt, 1973; Wang et al., 1975, 1976; Joho et al., 1975; Lai et 
al., 1973). Therefore, the genetic structure of these td mutants 
is essentially the same as that of lymphoid leukosis viruses. 
Because the deletion of this set of RNA sequences always cor­
relates with the lack of cell-transforming capacity of the virus, 
· this region is considered to be responsible for cell transformation
and thus defined as the src gene (Wang et al., 1976; Stehelin
et al., 1976a; Hayward, 1977; Hanafusa, 1977; Vogt, 1977; Wang,
1978). The extent of the deletion was originally thought to be
uniform for various td mutants (Wang et al., 1975).
In 1975, Sadaaki Kawai working in our laboratory at the time, 
obtained several isolates of this class of spontaneous deletion 
mutants of Schmidt-Ruppin strain of RSV (SR-RSV). Defined 
as transformation defective, these mutants do not cause any cell 
transformation in infected cultures. However, we obtained evi­
dence suggesting that, instead of the complete deletion of the 
src gene, some of the mutants still retain a small portion of the 
src gene (Kawai et al., 1977). Previously we isolated a mutant 
of RSV which is temperature sensitive (ts) in its capacity to 
transform cells, but not to replicate (Kawai and Hanafusa, 1971). 
Therefore, the mutation must be in the src gene. When cells are 
doubly infected with this ts mutant, tsNY68, and one of the td 
mutant isolate�, the products of some combinations were less 
temperature sensitive, indicating the formation of recombinants 
which had lost the ts lesion. The results were interpreted as 
indicating that these td mutants contained a small portion of src 
which corresponded to the temperature-sensitive lesion of the. 
ts mutant. Indeed, the size of the RNA of these td mutants was 
shown to be slightly larger than that of other standard leukosis 
viruses (Kawai et al., 1977). 
The first indication that the src gene originated from cellular 
DNA sequences came from a hybridization study by Stehelin 
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et al., (1976a,b). These investigators prepared DNA comple­
mentary to the src gene of RSV using reverse transcriptase. This 
cDNAs,c can hybridize with RNA of RSV but not with RNA of 
lymphoid leukosis viruses or td mutants. However, DNA of 
normal chicken cells showed a substantial degree of hybridization 
with this cDNAs,c• Furthermore, the sequences homologous to 
the src gene were detectable in DNA of normal cells of many 
avian species (Stehelin et al., 1976b) and also later in mammalian 
and fish DNAs when less stringent conditions were used for 
molecular hybridization (Spector et al., 1978a). This src-related 
DNA in normal cells is transcribed into RNA (Wang et al., 1977; 
Spector et al., 1978b), which sediments at approximately 26 S 
in a sucrose gradient. The amounts of src-related RNA in normal 
cells were independent of the level of expression of leukosis 
virus-related sequences present in DNA of chicken cells. Fur­
thermore, the 26 S src-related RNA is apparently not linked to 
the endogenous viral sequences, and src-related sequences and 
endogenous viral sequences were shown to reside at different 
sites on the cell chromosomes (Wang et al., 1977; Padgett et al., 
1977; Spector et al., 1978b). 
The amounts of such RNA species in various types of cells 
are shown in Table II. In normal uninfected chicken cells which 
happen to be the type expressing very little viral RNA, the 
amount of RNA transcripts of gag or env genes is extremely low 
TABLE II 
CONTENT OF GENE-SPECIFIC RNAs 1N VIRUS-INFECTED CELLS" 
Region 
analyzed 
gag 
pol 
env 
src 
C 
RNA content (copies/cell) 
Uninfected cells RA V-2-infected cells 
0.2 9,800 
NDb 9,400 
0.5 16,000 
5 7 
ND 17,000 
" From Hayward (1977). 
b Not determined. 
SR-RSV-infected 
cells 
10,000 
10,200 
20,000 
18,000 
19,500 
RNA TUMOR VIRUSES 261 
(Hayward and Hanafusa, 1973). In cells infected with the lym­
phoid leukosis virus, RAV-2, the amount of RNA transcripts of 
these genes is high because of the active synthesis of viral RNA. 
However, the level of about 5-10 copies of src-related sequences 
present in uninfected cells remains unchanged in the RA V-2 
infected cells, indicating that exogenous virus infection does not 
alter the extent of expression of endogenous src-related se­
quences (Hayward, 1977; Wang et al., 1977). Cells infected with 
RSV obviously contain large amounts of RNA transcripts of all 
four genes, because all of them are present in the sarcoma virus 
genome. 
The existence of sequences related to the src gene of RSV in 
DNA of normal chickens and other vertebrate cells suggests the 
idea that virus might have picked up these sequences and thus 
become oncogenic. However, in the past, attempts to obtain 
sarcoma virus from chickens infected with lymphoid leukosis 
viruses have failed. On the other hand, there are some obser­
vations which imply the process of the generation of murine 
sarcoma viruses (MSV). In contrast to the isolation of sarcoma 
viruses from spontaneous tumors in chickens, many strains of 
MSV now widely used were made in the laboratory. When mu­
rine leukemia virus was maintained by repeated passages in mice 
(Moloney, 1966), or rats (Harvey, 1964; Kirsten and Mayer, 
1967), sarcomas were formed in these animals. Viruses isolated 
from the resulting tumors were defective in replication; these 
isolates were called murine sarcoma viruses because they in­
duced foci on mouse cells and produced sarcoma in mice. In­
teresting observations were made when cDNAs homologous to 
the sarcoma virus and nonhomologous to helper leukemia se­
quences were employed to examine their homology with cellular 
and viral nucleic acids (Scolnick et al., I 973, 1975; Scolnick and 
Parks, 1974; Roy-Burman and Klement, 1975; Anderson and 
Robbins, 1976; Frankel and Fischinger, 1976, 1977). First, se­
quences specific to Kirsten sarcoma virus and Moloney sarcoma 
virus were not the same. Second, cDNA to Kirsten sarcoma 
virus-specific sequences hybridized well with rat cell DNA, but 
not with mouse cell DNA. Conversely, cDNA to Moloney sar­
coma virus sequences hybridized with DNA of mouse cells but 
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not with that of rat cells. Therefore, it appeared that each sar­
coma virus was generated via recombination with respective host 
cell sequences. 
Because we found that some td mutants of RSV retained a 
small portion of the src gene, we considered that these sequences 
might serve for homologous recombination with the cellular src­
related sequences, and thus increase the probability of generating 
sarcoma virus. Table III shows some data of early experiments. 
Td mutants were inoculated into the wing-web of newborn 
chicks. Newborn chicks were used because they were known 
to support growth of virus without immediate immunological 
response, and also because animals should provide a larger num­
ber of cells compared with in vitro tissue cultures; thus, this 
would increase the chance of recombination between viral and 
cellular genomes. 
By definition, td mutants do not cause cell transformationr 
and indeed did not produce tumors at the site of injection. Then, 
beginning at about 2 months, we noticed the appearance of tu­
mors, generally one, but sometimes in multiple numbers, at vari­
ous sites distal from the original injection site: back, breast, leg, 
and various internal organs. From every tumor we were able to 
recover viruses fully capable of inducing sarcomagenic trans­
formation both in vitro and in vivo. In order to rule out the 
Experiment 
2 
TABLE III 
FORMATION OF Soun TUMORS BY td MUTANTS OF SR-RSV 
Virus 
Control 
td IOI 
td 105 
td 107 
td 108 
RAV-I 
td 106 
td 107 
td IOI Repurified 
td 107A Repurified 
td 108 Repurified 
td 109 Repurified 
Number of chickens with 
solid tumors/total 
0/5 
2/5 
1/5 
2/4 
3/4 
0/8 
0/7 
2/7 
4/16 
0/15 
9/16 
4/8 
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possibility that the tumor formation was due to the presence of 
a minute amount of sarcoma virus as a contaminant in the td 
mutant stocks, the td mutants were carefully purified by terminal 
dilution passages. Injection with these viruses confirmed that the 
generation of sarcoma virus is reproducible as shown in Table 
III (exp. 2) (Hanafusa et al., 1977). 
It should be pointed out here that some td mutants were unable 
to produce tumors. Mutants which have complete deletions of 
the src gene, such as td106 and 107 A, cannot recombine with 
the cellular sequences. The long latency for the formation of 
tumors in general suggests a low frequency of the genetic inter­
action even in the positive cases. 
The viruses isolated from tumors were designated ''recovered 
avian sarcoma virus" (rASV) followed by the number of the 
chicken from which each virus was isolated. Foci of transformed 
cells induced by the recovered viruses were similar to each other, 
despite the varying origin of tissues where tumors were formed. 
They were rather distinct, however, from foci induced by stan­
dard Schmidt-Ruppin RSV from which the td mutants were 
derived. These results suggested that we had obtained a new 
type of sarcoma virus. The isolation of similar rASVs was ob­
served by Vigne et al. (1979). 
The scheme for the generation of rASV is essentially as shown 
in Fig. 1. In most cases the size of RNA of the recovered viruses 
was similar to that of Schmidt-Ruppin RSV. This was attributed 
to the restoration of the src gene, because RNA of rASV hy­
bridized with more than 90% of cDNAs,c, whereas RNA of td 
mutants used for generation of rASVs contained only 10 to 30% 
of src-specific sequences (Halpern et al., 1979). Therefore, one 
can conclude that from 70 to 90% of the src gene of recovered 
ASV is derived from the host cell sequences. 
The relationship of the src-specific sequences between re­
covered virus and standard RSV was studied by L.-H. Wang 
and others (Wang et al., 1978) by comparing RNase T 1-resistant 
oligonucleotide fingerprints. The fingerprint patterns were sur­
prisingly similar to each other, but RNA of several isolates of 
rASV consistently contained a new set of oligonucleotides. Fur­
thermore, we were able to obtain similar recovered viruses from 
quails infected with the same td mutants used for chickens. The 
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src c gag tnv 
FIG. I. The generation of rASV. The genetic structures of SR-RSV, its td 
mutant and rASV are schematically shown, based on data obtained from the size 
of RNAs, hybridization with cDNAs,c and T 1 oligonucleotide fingerprints. 
comparison of fingerprints of chicken-derived r ASV s and quail­
derived rASVs showed a few distinct differences between these 
two types of virus RNA, while RNAs of rASVs recovered from 
the same species of animals were identical to each other (Wang 
et al., 1979) (Fig. 2). These experiments demonstrated that the 
sequences regained in recovered ASV src gene were indeed de­
rived from cellular sequences present in each species of animals 
which were closely related but not identical. 
III. TRANSFORMATION AS A RESULT OF THE EXPRESSION OF 
NORMAL CELLULAR ENZYME 
The product of the src gene of RSV was first identified by 
Erikson and his associates (Brugge and Erikson, 1977; Purchio 
et al., 1977). They injected Schmidt-Ruppin RSV into newborn 
rabbits and produced tumors. Sera of rabbits carrying regressing 
RSV tumors were shown to have a capacity to precipitate a 
protein of molecular weight of about 60,000 from extracts of 
i • 
4'-
-t:, 
• 
t 
I
,. ,  
I 
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., 
� ' • 
.-. 
• 
w 
� 
, 
.. 'I .. 
-!>. � • 
' . 
-t> •• I•, 
iii, • y. 
FIG. 2. Fingerprint patterns of RNase T,-resistanl oligonucleotides of viral 32P-labeled RNAs. 32P-labled viral 60 to 70 S RNAs
were digested with RNase T,, and digestion products were separated by electrophoresis and homochromatography. (A) SR-RSV; 
(B) rASV-C 145 obtained from a chicken tumor; and (C) rASV-Q 3042-13 obtained from a quail tumor. Spots indicated by arrows
are src-specific oligonucleotides: open arrows are those present in SR-RSV RNA and solid arrows are those not present in RNA
of SR-RSV but present in rASV RNAs.
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RSV-transformed cells, but not of uninfected or lymphoid leu­
kosis virus-infected cells. Further studies showed that this pro­
tein is a phosphoprotein which has a protein kinase activity 
(Collett and Erikson, 1978; Levinson et al., 1978). 
When we applied this technique to extracts of cells transformed 
by rASVs, 60K proteins (p60) were precipitable by the antisera 
as expected, and the proteins were associated with a protein 
kinase activity (Karess et al., 1979). The protein kinase activity 
was detected by the transfer of phosphate from ')'-ATP to an 
aceptor protein molecule. In this case, antigen-antibody complex 
precipitated by the aid of staphylococcal protein A was mixed 
with [')'-32P]ATP. The most closely associated protein molecule, 
immunoglobulin became labeled with 32P. Therefore, as shown 
in Fig. 3, the heavy chain of IgG of about 52,000 daltons was 
strongly phosphorylated. In addition, in this particular experi­
ment phosphates were also transferred to p60 itself. Later studies 
by Hunter and Sefton (1980) showed that this protein kinase 
associated with the src protein is unique in phosphorylating ty­
rosine residues of substrate proteins rather than serine or thre­
onine residues, sites of phosphorylation by known cellular pro­
tein kinases. Because phosphorylation of proteins is known to 
be associated with various regulatory processes in cells, the in­
creased level of phosphorylating activity by the src protein may 
well serve as the trigger for the process of cell transformation; 
the analysis of this process is the current topic of research in 
many laboratories. 
Figure 3 also shows that extracts of nontransformed cells, 
either normal chicken cells or td virus-infected cells contain 
limited amounts of p60 precipitable by the same immune serum, 
and this protein showed the same protein kinase activity (Collett 
et al., 1978, 1979; Oppermann et al., 1979; Karess et al., 1979). 
An src-related protein in normal chicken cells can be found also 
in normal cells of many mammalian species (Oppermann et al., 
1979; Collett et al., 1979). The phosphorylation is specific to 
tyrosine residues, and the proteins are structurally very similar 
to the 60K pr:otein made in transformed cells (Hunter and Sefton, 
1980). As discussed before, normal cells are known to contain 
src-related nucleotides in both DNA and RNA. Therefore, it 
A B 
a b C d a b C d e f 
52- - 52-
F1G. 3. Autoradiogram of products of protein kinase reaction after electrophoresis in 8.5% polyacrylamide gel. (A) Trans­
formed and (B) nontransformed cells. (A) Kinase activity by immunoprecipitates of(a) SR-RSV-infected cells with nonimmune 
serum; (b) SR-RSV-infected cells with immune serum; (c) rASV-C 1441-infected cells with immune serum; (d) rASV-C 157-
infected cells with immune serum. (B) Kinase activity immunoprecipitated from uninfected cells (a, b, c) or tdl08-infected 
cells (d, e, f): (a, d) immune serum; (b, e) immune serum preabsorbed with virion proteins; (c, f) nonimmune serum. 
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This process itself is essentially similar to the transduction in 
bacteriophage, although the process of recombination involved 
in the transduction may not be similar. The cellular protein kinase 
gene is now linked to the viral genome, which has a strong 
promoter that allows efficient transcription of the entire viral 
genome, irrespective of the site of integration, which results in 
the production of a high level of the kinase. 
However, one still cannot dismiss another possibility: that a 
portion of the src gene retained by the td mutants could have 
a crucial role. In the retained portion, the sequences of viral src
and its cellular counterpart could be different; only p60 made 
by viral sequences could be effective for cell transformation. 
If the first scheme is correct, this means that the mere 
overproduction of a certain protein (such as protein kinase) could 
be the cause of cell transformation. At the moment, there is no 
clear indication whether viral and cellular products are func­
tionally different, and therefore we cannot make a definitive 
conclusion in the chicken system. However, with Moloney mu­
rine sarcoma virus, molecular cloning of the viral transforming 
sequences and its cellular counterpart was performed (Vande 
Woude et al., 1979). When cellular counterpart DNA was trans­
fected into normal cells, no cell transformation took place. But 
when the cellular counterpart DNA was ligated to the terminal 
repeats of the virus, the DNA efficiently induced cell transfor­
mation upon transfection (Oskarsson et al., 1980). These results 
support the idea described in the first scheme. 
IV. EXISTENCE OF MANY TRANSFORMING GENES 
It has become more apparent by now that there are many 
different transforming genes. The src gene of RSV is only one 
of them. Recently T. Hanafusa and others in our laboratory 
studied the genetic structure of Fujinami sarcoma virus as part 
of a comparative analysis of transforming genes of various strains 
of avian sarcoma virus (Wang et al., 1980; Hanafusa et al., 1980; 
Lee et al., 1980). This Fujinami sarcoma virus (FSV) was isolated 
in Japan at almost the same time as RSV was isolated, and is 
as potent as RSV in sarcomagenic action in chickens (Fujinami 
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and Inamoto, 1914). To our surprise, the genome of FSV does 
not contain the src sequences of RSV. The virus is very defective 
in replication, and the viral RNA is only 28 S or about 5000 
nucleotides. The FSV RNA contains viral sequences at both the 
5' and 3' termini, but the middle of the genome is substituted 
by a set of unique sequences. The viral RNA does not hybridize 
to cDNAs,c and contains no oligonucleotide specific to src. A 
large protein of molecular weight about 140,000 can be found in 
FSV-transformed cells by immunoprecipitation with antisera 
against the gag gene product (structural protein) of lymphoid 
leukosis viruses. This protein of 140,000 daltons (p l40) seems 
to be the only viral product found in FSV-transformed non-virus­
producing cells and thus is likely to be a transforming protein. 
The p140 of FSV also appears to be associated with a protein 
kinase activity which phosphorylates specifically tyrosine resi­
dues of substrate proteins (Feldman et al., 1980). Two other 
avian sarcoma viruses recently characterized, PRCII and Y73, 
appear to be similar to FSV rather than RSV, in their overall 
genetic structures (Vogt et al., 1980; Kawai et al., 1980). 
The genetic structures of some representative RNA tumor 
viruses are shown in Fig. 4, which illustrates the diversity of the 
genetic structure of the transforming retroviruses. The portions 
shown by the open bar are the inserts of unique sequences into 
the genomes of lymphoid leukosis virus. The viral sequences are 
probably essential in providing the large terminal repeats which 
ensure the integration and efficient transcription, and perhaps 
5'-terminal sequences required for packaging of viral RNA into 
virions. In many cases, the unique sequences have been shown 
to have homologous counterparts in DNA of normal vertebrate 
cells. In general, the inserts of all of these viruses are not com­
mon to each other, suggesting that many different sets of cellular 
sequences can act as transforming genes. Recent studies with 
FSV showed that the unique sequence of FSV is homologous 
to the genome of feline sarcoma virus (Shibuya et al., 1980). 
This means that the sarcomagenic sequences of a chicken virus 
and a feline virus have a common origin; probably the cognate 
genes in normal chicken and feline cell DNA were picked up 
independently by avian and feline retroviruses. Perhaps it is also 
0 
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FIG. 4. The genetic structures of some representative retroviruses. The regions 
of the genomes shown by the open bars are the inserts unique to each virus. 
Data are obtained from Wang et al. (1975), Bister et al. (1979), Hanafusa et al. 
(1980), Shih et al. (1978), Donoghue et al. (1979), and Shields et al. (1979). 
worth mentioning that the gene products of some acute leukemia 
viruses such as avian erythroblastosis virus appear to be spe­
cifically involved in the differentiation process of blood cells 
(Graf and Beug, 1978; Graf et al., 1980). 
It seems likely, therefore, that the sequences we call trans­
forming genes are the genes of cellular enzymes possibly involved 
in various regulatory processes. Linking these genes with virus 
genomes could be considered as natural cloning of cellular genes, 
with retrovirus serving as cloning vehicles. Such a recombination 
may also occur with other cellular genes, but unless some overt 
changes such as cell transformation are induced·, such recom­
binants would not be recognized and selected for. 
The comparison shown in Fig. 4 illustrates that the structure 
of RSV is unique among these transforming viruses because it 
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is the only virus in which its transforming gene is located outside 
of the replicative region of prototype leukosis virus. As a con­
sequence, RSV is the only known transforming virus which is 
not defective in virus replication. When we demonstrated the 
defectiveness of Bryan strain of RSV for the first time (Hanafusa 
et al., 1963), Rubin pointed out the possibility that the defec­
tiveness of the replicative function of the virus is correlated with 
its transforming capacity, considering the model of defective 
transducing phages (Rubin, 1964). This concept was quickly dis­
missed when we found that other RSV strains are nondefective 
(Hanafusa, 1964). In _retrospect, Rubin's concept may be basi­
cally right. As seen in a few examples shown in Fig. 4, nearly 
all transforming retroviruses are defective because of the sub­
stitution of a significant part of the viral genome by cellular 
sequences. It is intriguing that nondefective RSV was an excep­
tional existence, since this class of RSV has been· most invaluable 
for the genetic analysis of the transforming virus, and for the 
analysis of the transformation process in infected cells. 
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